BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 400931)

  • 1. Comparative studies of cefoxitin and cephalothin: an overview.
    Neu HC
    Rev Infect Dis; 1979; 1(1):144-51. PubMed ID: 400931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefoxitin: an overview of clinical studies in the United States.
    Neu HC
    Rev Infect Dis; 1979; 1(1):233-9. PubMed ID: 400937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a clinical trial of cefoxitin, a new cephamycin antibiotic.
    McCloskey RV
    Antimicrob Agents Chemother; 1977 Nov; 12(5):636-41. PubMed ID: 335968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefoxitin sodium and cephalothin in the treatment of serious infections.
    Jahre JA; Neu HC; Parry MF; Goldberger MJ
    J Antimicrob Chemother; 1978 Jul; 4(B):105-11. PubMed ID: 357374
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing vaginal hysterectomy.
    Benigno BB; Evrard J; Faro S; Ford LC; LaCroix G; Lawrence WD; Ling FW; McNeeley SG; Nichols DH; Sweet RL
    Surg Gynecol Obstet; 1986 Nov; 163(5):421-7. PubMed ID: 3535134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of cefoxitin: an approach to the analysis of laboratory data.
    Brown KR; Getson AJ; Gould AL; Martin CM; Ricci FM
    Rev Infect Dis; 1979; 1(1):228-32. PubMed ID: 400935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprophylaxis with cefoxitin and cephalothin in orthopedic surgery: a comparison.
    Rosenfeld MB; Campos J; Ratzan KR; Uredo I
    Antimicrob Agents Chemother; 1981 May; 19(5):826-30. PubMed ID: 7027924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cephalothin, cefoxitin, or metronidazole in elective colonic surgery? A single-blind randomized trial.
    Panichi G; Pantosti A; Giunchi G; Tonelli F; D'Amicis P; Fegiz G; Gianfrilli Mastrantonio P; Luzzi I; Grandolfi ME
    Dis Colon Rectum; 1982; 25(8):783-6. PubMed ID: 6756828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two systemic antibiotics for the prevention of complications in elective colorectal surgery.
    Antonelli W; Borgani A; Machella C; Morri F; Parrino A; Poloni M; Sbriccoli A
    Ital J Surg Sci; 1985; 15(3):255-8. PubMed ID: 3905700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative clinical evaluation of a new cephyamycin antibiotic, cefoxitin, in acute bacterial infections.
    Del Negro G; Francisco W; Godoy CV
    Rev Inst Med Trop Sao Paulo; 1980; 22(1):30-6. PubMed ID: 7001604
    [No Abstract]   [Full Text] [Related]  

  • 11. Infections due to endemic, multiply resistant gram-negative rods: sensitivity to and therapy with cefoxitin.
    Alford RH
    Rev Infect Dis; 1979; 1(1):175-82. PubMed ID: 400932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of cefotetan and cefoxitin in the treatment of intra-abdominal infections.
    Lewis RT; Duma RJ; Echols RM; Jemsek JG; Najem AZ; Press RA; Stone HH; Ton GT; Wilson SE
    Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):728-35. PubMed ID: 3281463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of cefotiam versus cephalothin in the therapy of skin and soft tissue infections.
    Lentino JR; Stachowski M; Strikas R; Parrillo P
    Antimicrob Agents Chemother; 1984 Jun; 25(6):778-80. PubMed ID: 6331302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1979 Jan; 17(1):1-37. PubMed ID: 369806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of therapy with cefoxitin.
    McCloskey RV; Goren RC
    Clin Ther; 1980; 3(2):66-79. PubMed ID: 7448845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of infections in hospitalized patients with ticarcillin plus clavulanic acid. A comparative study.
    Holloway WJ
    Am J Med; 1985 Nov; 79(5B):168-71. PubMed ID: 4073086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefoxitin therapy in aerobic, anaerobic, and mixed aerobic-anaerobic infections.
    LeFrock JL; Schell RF; Carr BB; Kowalsky SF; Tillotson JR
    Drug Intell Clin Pharm; 1982 Apr; 16(4):306-12. PubMed ID: 7067621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of cephalothin- and cefalozin-resistant infections using cefoxitin].
    Shah PM; Helm EB; Stille W
    MMW Munch Med Wochenschr; 1978 Mar; 120(11):375-6. PubMed ID: 306521
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative evaluation of cefmenoxime versus cefoxitin in serious infections.
    Bechard DL; Hawkins SH; Sutherland SC
    Am J Med; 1984 Dec; 77(6A):13-6. PubMed ID: 6097117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter comparison of cefotetan and cefoxitin in the treatment of acute obstetric and gynecologic infections.
    Hemsell DL; Wendel GD; Gall SA; Newton ER; Gibbs RS; Knuppel RA; Lane TW; Sweet RL
    Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):722-7. PubMed ID: 3281462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.